ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Accounts receivable, net

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndAccounts receivable, net (Million USD)YoY (%)
Dec 31, 20257,929+14.50%
Dec 31, 20246,925+5.48%
Dec 31, 20236,565+5.58%
Dec 31, 20226,218-4.15%
Dec 31, 20216,487+1.14%
Dec 31, 20206,414+18.23%
Dec 31, 20195,425+4.69%
Dec 31, 20185,182-1.28%
Dec 31, 20175,249+61.61%
Dec 31, 20163,248-4.97%
Dec 31, 20153,418-14.25%
Dec 31, 20133,986-48.13%
Dec 31, 20117,684+6.96%
Dec 31, 20107,184

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat